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Inflammatory cells  have  surface  receptors  for  immune complexes  (1-12).  These 
receptors  play  a  functional role  in  phagocytosis  (13)  and  cell-mediated cytotoxic 
reactions (14-21); and may be involved in immunoregulation (22,  23). The binding 
of IgG complexes to lymphocytes and macrophages does not require divalent cations 
(3,  7, 8). On the other hand, macrophage binding to IgM complexes has been shown 
to require Ca  ++  (3).  IgM complex receptors have also been detected on lymphocytes 
of several  species  (9-11).  In  this  report  we  show  that  mouse  lymphocytes exhibit 
optimal binding to IgM complexes in the presence of Mg  +÷ in contrast to macrophage 
IgM  complex binding. In  addition to  their  functional implications, these  findings 
allow one to distinguish IgG from IgM binding and macrophage from  lymphocyte 
IgM binding by their differential divalent cation requirements. 
Materials and Methods 
Lymphocyte suspensions were prepared from spleens, thymi, and lymph nodes of C3H/HeJ 
and CBA/Jax  mice and used at  a  concentration of 107 cells/ml in barbital-buffered saline 
(BBS), pH 7.2. Macrophages from thioglycollate-induced  peritoneal exudates of outbred Swiss 
(CD-1)  mice were cultured in monolayer on glass coverslips  as previously described (13) and 
washed in BBS before use. Antisera to ox erythrocytes (ORBC) were collected 5 d after primary 
or tertiary immunization of CBA mice with 0.2 ml of 50% ORBC. The sera were fractionated 
by ammonium sulfate precipitation and Sepharose  6B  (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc., Piscataway, N. J.) column chromatography; the leading half of the 19S peak 
from primary sera and the trailing half of the 7S peak from hyperimmune sera were collected 
for use. The 19S IgM fraction had a complement-dependent hemolytic titer of 256 and was 
used at a dilution of 1:10 in rosette assays. The 7S IgG, titer of 128, was used at a dilution of 
1:50. 2% suspensions of ORBC sensitized with the appropriate antibodies were mixed with 
equal volumes of lymphocyte suspensions or were  added  to adherent macrophage cultures. 
....  ÷+  r  ++  Unsenslttzed erythrocytes served as controls. Various concentrations of Mg  o  Ca  (chloride 
salts) or of EDTA or EGTA (sodium salts) were included as indicated below. After 15 min at 
37°C the lymphoid cells were examined for rosette formation. 
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TABLE  I 
IgM-ORBC Binding By Lymphocytes And Macrophages 
Source  15 mM Mg  ++ *  15 mM Ca  ++ 
Spleen:~  22 +  1.5  u  3 + 0.5 
Lymph Node  11 +  1.5  I 4- 0.3 
Thymus  9 4- 1.0  1 4- 0.2 
Peritoneal  Macrophages§  4 4- 1.0  96 4-  1.5 
* Divalent cation-free  BBS did not support IgM-sensitized  erythrocyte binding by either 
macrophages or lymphocytes. 
:~ Similar results were obtained from CBA, C3H, and CD- I mice. 
§ Obtained from CD-I mice. 
[I Data  repr'-,~ents mean  4- SEM of the  percentage of rosette-forming cells  from four 
experiments. Criteria for rosette  formation were two or more erythrocytes attached to 
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FIo.  1.  Mg  ++ requirement  for binding of IgM-sensitized ORBC  to mouse spleen cells. The data 
shown represent the percentage of rosette forming cells  (% RFC)  and standard error of the mean 
(vertical  bars)  from four experiments. Standard  errors of <:1%  are not shown. In addition  to the 
data shown in the graph, Ca  ++ tested in  I  mM increments from 0  to 5 did not support spleen cell 
binding to IgM-sensitized erythrocytes. Spleen cells were obtained from CBA mice. Similar results 
have  been  obtained  with  C3H  and  CD-1  spleen  cells.  (0)  IgM,  Mg++;  (O)  IgM,  Ca++;  (A) 
unsensitized, Mg  ++. 
Results 
Spleen cells, thymocytes, lymph node cells, and macrophages were tested for their 
divalent cation requirement for optimal IgM complex binding. As shown in Table I, 
Mg  ++ supported IgM complex binding by lymphocytes, whereas Ca  ++ did not. The 
reverse was found with macrophages: Ca  ++, but not Mg  ++, supported IgM complex 
binding. Different concentrations of Mg  ++ and Ca  ++ (0-25  mM) were used to assess 
the concentration required for optimal IgM complex binding by spleen cells (Fig. 1). 
Increased IgM rosette formation was seen as the concentration of Mg  ++ increased up 
to  20  raM.  Ca  ++  did  not  support  lymphocyte binding to  IgM complexes at  any 
concentration; indeed, Ca  ++ was inhibitory when added to the rosette-forming  mixture 
that contained an optimal concentration of Mg  ++ (data not shown). 
The divalent cation requirement for IgM complex binding was further studied by 
inhibition with  chelating agents.  As  shown  in  Table  II,  the  addition  of EDTA 
decreased IgM rosette formation by spleen cells at each dose tested; in contrast, 5 mM 
EGTA produced an increase  in IgM rosette formation, and higher concentrations of 
EGTA were less inhibitory than comparable levels of EDTA. Table III shows that 1530  WALIA  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Inhibition Of IgM Complex Binding To Spleen Cells By Chelating Agents 
Chelating agent final con- 
centration* 
Percentage of control with 20 mM Mg  ÷÷ 
EDTA  EGTA 
mM 
O*  100§  100 
5  27  136 
10  18  66 
15  14  39 
20  14  39 
25  9  36 
* Chelating agents were directly added to the wells that contained IgM-sensitized ORBC 
and spleen cells. Final concentrations are shown. 
:~ ORBC and spleen ceils were prepared in BBS that contained 20 mM Mg  +÷. 
§ Data were obtained from three samples for each point. The control contained 11  +  1% 
lgM-rosette-forming cells. The percentage of control was calculated as:  (percentage of 
rosette-forming cells in sample with chelating agent/percentage of rosette-forming cells 
in control)  X  100. 
TAaLE III 
Antibody-sensitized ORBC Binding By Macrophages 
Group  BBS that contained 
ORBC sensitized  with 
Unsensi- 
IgG  IgM  tlzed 
1  No divalent cations  84*  5  4 
2  2 mM Ca  ++  88  99  5 
3  5 mM EDTA:~  85  6  2 
4  Reconstituted to 2 mM Ca*+§  93  95  3 
* Numbers shown are the percentage of macrophages binding three or more erythrocytes. The 
results  shown  are  representative of a  series  of three experiments.  Similar results  have been 
obtained with resident  (nonelicited)  peritoneal macrophage, except  that  the number of cells 
expressing  easily detectable IgG or IgM complex receptors was lower. 
:~ For inhibition studies,  both sensitized  ORBC and macrophages were washed with the chelating 
agent. EGTA also inhibited IgM complex binding by macrophages. 
§ Treated with EDTA as in group 3, washed with BBS, and 2 mM Ca  ++ added. 
macrophage binding of IgM complexes in the presence of 2 mM Ca ++ was significantly 
reduced after washing macrophages  and IgM-sensitized  ORBC  with 5  mM  EDTA; 
the rosetting activity could be reconstituted by the addition of Ca ++. Similar results 
were  obtained with  EGTA  (data  not shown).  As  reported  by others  (3,  7),  neither 
lymphocyte  nor  macrophage  IgG  complex  binding  was  dependent  upon  divalent 
cations.  51  -  7%  of spleen  cells  bound  to  IgG-sensitized  erythrocytes  in  divalent 
cation-free BBS.  This was essentially unaffected  by the addition  of either chelating 
agents or divalent cations. Similarly, 88 _  4% of macrophages bound IgG-sensitized 
ORBC, irrespective of divalent cation concentration (Table III). 
Discussion 
We have thus demonstrated a  differential  divalent cation requirement  for macro- 
phage  and  lymphocyte  Fc  receptor  binding  that  is  dependent  upon  the  type  of 
lymphoid cells involved and the class of antibody used.  Mouse lymphocytes require 
Mg  ++  but  not  Ca ++  for  optimal  IgM  complex  binding.  In  contrast,  macrophage 
rosette  formation  with  IgM-sensitized  erythrocytes  is  supported  by  Ca ++  but  not WALIA ET AL.  BRIEF  DEFINITIVE REPORT  1531 
Mg  ++. The experiments with chelating agents support these findings. Ca  ++ is bound 
equally well  by either chelating agent  (24). Correspondingly, inhibition of Ca  ++- 
dependent IgM complex binding to macrophages was affected equally by EDTA or 
EGTA. Mg  ++, on the other hand, has a higher affinity for EDTA than EGTA (24). 
Thus, Mg++-dependent IgM complex binding to lymphocytes  was inhibited to a lesser 
degree by EGTA than EDTA. Indeed, 5 mM EGTA in the presence of 20 mM Mg  ++ 
enhanced lymphocyte IgM complex binding, probably by removing cell-bound Ca  ++ 
and allowing further Mg  ÷+ attachments to take place.  IgG complex binding to both 
lymphocytes and macrophages, on the other hand, is divalent cation independent. 
Previous  results  from our laboratories have indicated that the lymphocytes that 
bind IgM complexes through Fc receptors  include both T and B cells (11). It is likely 
that  IgM  Fc  receptor  binding  to  lymphocytes and  macrophages  has  functional 
significance.  It  has  been  shown,  for  example,  that  lymphocytes can  function as 
cytotoxic effector cells against IgM-sensitized target cells (14-21).  IgM antibody may 
also participate in thymus-dependent helper activity by IgM Fc receptor interaction 
(22, 23). Macrophages and T cells could be involved in such cellular collaboration by 
binding to IgM complexes. The molar concentration of  Mg  ÷÷ required for lymphocyte 
IgM complex binding in vitro would seem inconsistent with physiological concentra- 
tions. However, increased concentrations of  Mg  ++ might be available at the membrane 
during inflammatory  reactions. Mg  ++ and Ca  ++ have been implicated in distinct steps 
during cellular immune reactions (25-27). 
The enhanced binding of IgM complexes  affected by divalent cations could be a 
result of stereochemical modifications in the Fc region of IgM or its corresponding 
receptor  site.  Alternatively, the  divalent  cations  could  participate  in  the  ligand 
interaction by forming Ca  ++ or Mg  ++ bridges between the receptor and the IgM Fc. 
The present data do not allow a critical distinction between these possibilities. X-ray 
crystallography studies  that  compare  Ca  ++  and  Mg  ++  complexes  with  hydrated 
organic molecules have shown some fundamental differences in the binding properties 
of these two divalent cations (24, 28). Ca  ÷+  displays a  greater number of ligands 
(higher coordination numbers) than Mg  ++, and the cation ligand distances of Ca  ÷+ 
are greater than those of Mg  ++. Both Ca  ++ and Mg  ++ coordinate to oxygen atoms, 
whereas  Mg  ++  also  coordinates  to  nitrogen  atoms.  It  is  conceivable  that  these 
differences  in  the binding properties of Ca  ++  and Mg  ++  could be  responsible  for 
differences  observed  in  binding  of IgM  to  its  Fc  receptor  on  macrophages  vs. 
lymphocytes. 
Summary 
We have found that Mg  ++ supports IgM complex binding to mouse lymphocytes 
but not to macrophages. In contrast, Ca  ++ supports IgM complex binding to macro- 
phages but not lymphocytes. IgG complex binding to both lymphocytes and macro- 
phages is divalent cation independent. These findings allow one to distinguish IgG 
from IgM binding and macrophage from lymphocyte IgM complex binding by their 
differential divalent cation requirements. 
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Received  for publication 19 Februa~ 1980. 1532  WALIA ET  AL.  BRIEr  DEFINITIVE REPORT 
References 
1.  Lo Buglio, A. F., R. S. Cotran, andJ. H.Jandl. 1967. Red cells coated with immunoglobulin 
G binding and sphering by mononuclear cells in man. Science (Wash. D. C.).  158:1582. 
2.  Lay, W. H., and V. Nussenzweig.  1968. Receptors for complement on leukocytes. J. Exp. 
Med.  128:991. 
3.  Lay, W. H., and V. Nussenzweig.  1969. Ca ++ dependent binding of antigen-19S antibody 
complexes to macrophages.J. Immunol. 102:1172. 
4.  Spitler, L., H.  Huber, and  H.  H. Fudenberg.  1969. Inhibition of capillary migration by 
antigen-antibody complexes. J. Immunol. 102:404. 
5.  Bianco, (2., R. Patric, and V. Nussenzweig.  1970. A population of lymphocytes bearing a 
membrane receptor for antigen-antibody-complement complexes. I. Separation and char- 
acterization.J. Exp. Med.  132:702. 
6.  Basten, A., J. F. A. P. Miller, J.  Sprent, and J.  Pye.  1972. A  receptor for antibody on B 
lymphocytes. I. Method of detection and functional significance.J. Exp. Med.  135:610. 
7.  Yoshida, T.  O.,  and  B.  Andersson.  1972. Evidence  for a  receptor recognizing antigen- 
complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand. 
J. Immunol. 1:401. 
8.  Dickler, H.  B.,  and  H.  G.  Kunkel.  1972. Interaction  of aggregated y-globulin with  B 
lymphocytes. J. Exp. Med.  136:191. 
9.  Webb, S. R., and M. D. Cooper. 1973. T cells can bind antigen via cytophilic IgM antibody 
made by B cells.J. Immunol. 111:275. 
10.  Moretta,  L.,  M.  Ferrarini, M.  L.  Durante,  and  M.  C.  Mingari.  1975. Expression of a 
receptor for IgM by human T  cells in vitro. Eur. J. Immunol. 5:565. 
11.  Lamon, E. W., B. Andersson, H. D. Whitten, M.  M.  Hurst, and V. Ghanta.  1976. IgM 
complex receptors on subpopulations of murine lymphocytes. J. Immunol. 116:1199. 
12.  Walia, A. S., B.  Andersson, E.  W. Fuson, and  E.  W.  Lamon.  1979. The enrichment  of 
thymocytes bearing (23 receptors following cortisone involution. Cell. Immunol. 43:176. 
13.  Griffin, F. M., Jr., C. Bianco, and S. (2. Siiverstein. 1975. Characterization of the macro- 
phage receptor for complement and demonstration of its functional independence from the 
receptor for the Fc portion of immunoglobulin G.J. Exp. Med.  141:1269. 
14.  Lamon, E. W., H. M. Skurzak, B. Andersson, H. D. Whitten, and E. Klein. 1975. Antibody- 
dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM 
and IgG with specificity for MLV determined antigen(s). J. Immunol. 114:1171. 
15.  Lamon, E. W., H.  D. Whitten, H.  M.  Skurzak, B.  Andersson, and  B.  Lidin.  1975. IgM 
antibody dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system. The 
involvement of T  and B lymphocytes as effector cells. J. Immunol. 115:1288. 
16.  Lamon, E. W., H. D. Whitten, B. Lidin, and H. H. Fudenberg. 1975. IgM-induced tumor 
cell cytotoxicity mediated by normal thymocytes.J. Exp. Med.  142:542. 
17.  W~.hlin, B., H. Perlmann, and P. Perlmann.  1976. Analysis by a plaque assay of IgG- or 
IgM-dependent cytolytic lymphocytes in human blood.J. Exp. Med.  144:1375. 
18.  Fuson,  E.  W.,  and  E.  W.  Lamon.  1977. IgM-induced ceil-mediated cytotoxicity with 
antibody and effector cells of human origin. J. Immunol. 118:1907. 
19.  Lamon,  E.  W., M.  W.  Shaw,  S. Goodson,  B.  Lidin, and  A.  S. Walia.  1977. Antibody- 
dependent cell-mediated cytotoxicity in  the Moloney sarcoma virus system. Differential 
activity of IgG and IgM with different subpopulations of lymphocytes. J. Exp. Med.  145: 
302. 
20.  Fuson, E. W., H. D. Whitten, R. D. Ayers, and E. W. Lamon.  1978. Antibody-dependent 
cell-mediated cytotoxicity by human lymphocytes. I. Comparison of IgM- and IgG-induced 
cytotoxicity.  J. Immunol. 120:1726. 
21.  Fuson, E. W., A. S. Walia, B. A. Cox, and E. W. Lamon.  1979. Antibody-dependent cell- 
mediated cytotoxicity in the Moloney sarcoma virus system: no requirement for exogenous 
(25. Clin. Immunol. Immunopathol. 14:35. WALIA ET AL.  BRIEF DEFINITIVE REPORT  1533 
22.  Moretta, L., S. R. Webb, C. E. Grossi, P. M. Lydyard, and M. D. Cooper. 1977. Functional 
analysis of two human subpopulations. Help and suppression of B cell responses by T cells 
bearing receptors for IgM (TM) or IgG (TG).J. Exp. Med. 146"184. 
23.  Collisson,  E. W., B. Andersson, and E. W. Lamon.  1979. Modulation of hapten-specific 
antibody  responses  with  anticarrier  antibody.  I.  Differential  effects  of IgM  and  IgG 
anticarrier on primary direct and indirect hapten-specific-plaque-forming cells. Proc. Soc. 
Exp. Biol. Med. 162:194. 
24.  Williams,  R. J.  P.  1976. Calcium  chemistry  and  its  relation  to biological  function.  In 
Calcium in Biological Systems. Symposia of the Society for Experimental  Biology. C. J. 
Duncan, editor. Cambridge University Press, Cambridge. 2. 
25.  Plaut, M.,J. E. Bubbers, and C. S. Henney. 1976. Studies on the mechanism of lymphocyte- 
mediated cytolysis. VII. Two stages in the T  cell-mediated lytic cycle with distinct cation 
requirements. J. Immunol. 116:150. 
26.  Golstein,  P.,  and  E.  T.  Smith.  1976. The  lethal  hit  stage of mouse T  and  non-T cell- 
mediated cytolysis: differences in cation requirements and characterization of an analytical 
"cation pulse" method. Eur.J. Immunol. 6:31. 
27.  Gately, M. K., and E. Martz. 1977. Comparative studies on the mechanism of non-specific, 
Con-A-dependent cytolysis and specific T  cell-mediated cytolysis.J. Immunol. 119:.1711. 
28.  Einspahr,  H., and  C.  E.  Bugg.  1977. Crystal structures  of calcium complexes of amino 
acids,  peptides  and  related  model  systems.  In  Calcium  Binding  Proteins  and  Calcium 
Function.  R.  H.  Wasserman,  R.  A.  Corradino,  E.  Carafali,  R.  H.  Kretsinger,  D.  H. 
MacLennan, and F. L. Seigel, editors. Elsevier North-Holland, Inc., Amsterdam.  13. 